Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.

Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page
- Check4 days agoChange DetectedNew study locations and investigators have been added, including The Catholic University of Korea Yeouido St. Mary’s Hospital, Hyun-Kook Lim, Jordi Matias Guiu, Gilbert, AZ, and an updated total of 412 locations. IPD sharing-related documents and links (CSR, SAP, Study Protocol, IPD Sharing URL) were added, along with IPD plan description and sponsor/collaborator information.SummaryDifference0.4%

- Check11 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 was removed on the page, indicating a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check20 days agoChange DetectedAdded Open-Label Extension ADEPT-3 for KarXT in psychosis associated with Alzheimer's disease, a 52-week global, multicenter rollover with new sites and investigators and current recruitment status. Replaced the previous ADEPT-3 description that included KarX-EC with a KarXT-only version and updated site details.SummaryDifference0.3%

- Check35 days agoChange DetectedThe page now displays a Last Update Posted timestamp in the Study Record Dates section, and the Last Update Posted (Estimated) field has been removed.SummaryDifference0.0%

- Check42 days agoChange DetectedMinor version update: Revision changed from v3.3.3 to v3.3.4, with no changes to core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedLocations updated: two new sites in Tokyo (tabashi City, 173-0015 and Setagaya-Ku, 156-0057) were added and a Tampa site was withdrawn, bringing the total locations to 411.SummaryDifference0.2%

Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.